Agostini HT, Silva R, Holz FG, Larsen M, et al. Impact of retinal thickness fluctuations with ranibizumab versus aflibercept in neovascular age-related macular degeneration (SALT): 12-month results from a multicentre, randomised, phase IV trial. Br J Ophthalmol 2025 Jul 24:bjo-2024-326526. doi: 10.1136/bjo-2024-326526.
PMID: 40707177